tiprankstipranks
Dr. Reddy's Laboratories Ltd. (IN:DRREDDY)
:DRREDDY
India Market
DRREDDY
Dr. Reddy's Laboratories Ltd.
RESEARCH TOOLSreports
Want to see IN:DRREDDY full AI Analyst Report?

Dr. Reddy's Laboratories Ltd. (DRREDDY) Financial Statements

10 Followers

Dr. Reddy's Laboratories Ltd. Financial Overview

Dr. Reddy's Laboratories Ltd.'s market cap is currently ₹1.09T. The company's EPS TTM is ₹51.43; its P/E ratio is 24.38; and it has a dividend yield of 0.63%. Dr. Reddy's Laboratories Ltd. is scheduled to report earnings on May 12, 2026, and the estimated EPS forecast is ₹9.60. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 335.93B₹ 325.54B₹ 279.16B₹ 245.88B₹ 214.39B
Gross Profit₹ 177.26B₹ 190.43B₹ 163.61B₹ 139.34B₹ 113.84B
Operating Income₹ 46.44B₹ 71.84B₹ 67.73B₹ 57.14B₹ 29.48B
EBITDA₹ 67.05B₹ 88.84B₹ 79.29B₹ 66.05B₹ 47.74B
Net Income₹ 42.85B₹ 56.54B₹ 55.68B₹ 45.07B₹ 23.57B
Balance Sheet
Cash & Short-Term Investments₹ 87.81B₹ 57.91B₹ 81.47B₹ 61.80B₹ 44.37B
Total Assets₹ 579.35B₹ 492.99B₹ 387.52B₹ 322.85B₹ 296.65B
Total Debt₹ 77.34B₹ 46.77B₹ 20.02B₹ 13.47B₹ 33.84B
Net Debt₹ 61.97B₹ 32.11B₹ 12.91B₹ 7.69B₹ 18.99B
Total Liabilities₹ 198.89B₹ 155.82B₹ 106.97B₹ 89.99B₹ 106.13B
Stockholders' Equity₹ 377.06B₹ 333.39B₹ 280.55B₹ 230.99B₹ 190.53B
Cash Flow
Free Cash Flow₹ 30.51B₹ 18.92B₹ 18.00B₹ 40.01B₹ 9.06B
Operating Cash Flow₹ 53.84B₹ 46.43B₹ 45.43B₹ 58.87B₹ 28.11B
Investing Cash Flow₹ -67.03B₹ -51.02B₹ -40.28B₹ -41.37B₹ -26.39B
Financing Cash Flow₹ 12.73B₹ 11.86B₹ -3.76B₹ -26.86B₹ -2.42B
Currency in INR

Dr. Reddy's Laboratories Ltd. Earnings and Revenue History

Income Statement >

Dr. Reddy's Laboratories Ltd. Debt to Assets

Balance Sheet >

Dr. Reddy's Laboratories Ltd. Cash Flow

Cash Flow >

Dr. Reddy's Laboratories Ltd. Forecast EPS vs Actual EPS

Earnings >